孕激素抑制雌激素受体介导的炎症途径在脑内出血后
Hengyang Ouyang1, Xiaobing Zhou2, Zhiming Zhang3
1Huankui Academy, Nanchang University, Nanchang, Jiangxi, China.
Pakistan journal of pharmaceutical sciences
|September 25, 2025
概括
孕激素通过减少大脑胀和炎症,在脑内出血 (ICH) 中提供神经保护. 它调节雌激素受体β (ER-β) /托尔类受体4 (TLR4) /NF-κB通路,表明ICH治疗的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 脑内出血 (ICH) 是一种严重的神经疾病,治疗选择有限.
- 了解神经保护的分子机制对于开发有效疗法至关重要.
研究的目的:
- 为了研究孕激素在ICH后的神经保护作用.
- 在ICH模型中阐明参与孕激素作用的分子通路.
主要方法:
- 在ICH的小鼠模型中,使用孕激素,ER激动剂或ER-βsiRNA进行治疗.
- 评估了神经功能,大脑,以及炎症性细胞因子水平.
- 在脑组织和微质细胞中分析了包括ER-β,TLR4和NF-κB在内的分子标.
主要成果:
- 孕激素显著改善了神经功能,并减少了ICH后的大脑.
- 孕激素抑制了ER-β的表达,并降低了炎症媒介 (PGE2,TNF-α,IL-1β).
- 孕激素通过ER-β调节抑制TLR4和NF-κB p65表达,这种效应被ER激动剂逆转.
结论:
- 在ICH模型中,孕激素显示出显著的神经保护作用.
- 神经保护通过ER-β/TLR4/NF-κB信号通路进行介导.
- 孕激素在治疗炎症和改善ICH后的结果方面具有前景.
更多相关视频
08:02Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
7.1K
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.8K
相关概念视频
01:22Hormonal Regulation of the Menstrual Cycle
1.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K